Super-oxidized solution inhibits IgE-antigen-induced degranulation and cytokine release in mast cells

International Immunopharmacology

Volumn 7, Issue 8, 2007, Pages 1013-1024

  Medina Tamayo, J ^a   Sanchez Miranda E ^a   Balleza Tapia, H ^a   Ambriz, X ^a   Cid, M E ^a   Gonzalez Espinosa D ^b   Gutierrez A A ^b   Gonzalez Espinosa C ^a  

^a Pharmacobiology Department   (Mexico)

^b National Institute of Rehabilitation   (Mexico)

Author keywords

Allergy; Cytokine production; Degranulation; IgE receptor; Mast cell; Super oxidized solution

Indexed keywords

ANTIALLERGIC AGENT; ANTIGEN; BETA N ACETYLHEXOSAMINIDASE; CALCIUM; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CALCIUM MOBILIZATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; IMMEDIATE TYPE HYPERSENSITIVITY; MAST CELL DEGRANULATION; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; BLOTTING, WESTERN; BONE MARROW CELLS; CALCIUM; CELL DEGRANULATION; CELL SURVIVAL; CYTOKINES; DISINFECTANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROGEN PEROXIDE; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, INBRED STRAINS; MITOGEN-ACTIVATED PROTEIN KINASES; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; RECEPTORS, IGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM HYPOCHLORITE; TYROSINE;

EID: 34249985328     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.03.005     Document Type: Article

References (44)

1. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
2. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponski A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
3. Kitamura Y. Heterogeneity of mast cells and phenotypic changes between subpopulations. Annu Rev Immunol 7 (1989) 59-76
4. Lantz C.S., Boesiger J., Song C.H., Mach N., Kobayashi T., Mulligan R.C., et al. Role of Interleukin 3 in mast cell and basophil development and parasite immunity. Nature 392 (1998) 90-93
5. Gilfillan A.M., and Tkaczyk Ch. Integrated signalling pathways for mast cell activation. Nat Rev Immunol 6 (2006) 218-230
6. Charlesworth E.N. The role of basophils and mast cells in acute and late reactions in the skin. Allergy 52 (1997) 31-43
7. Galli S.J., Metcalfe D.D., Arber D.A., and Dvorak A.M. Basophils and mast cells and their disorders. In: Beutler E., Litchman M.A., Coller B.S., Kipps T.J., and Seligsohn U. (Eds). Williams hematology (2005), McGraw-Hill, New York 538-592
8. Foreman J.C. In: Foreman J.C. (Ed). Immunopharmacology of mast cells and basophils (1997), Academic Press, New York 1-3
9. Undem B.J., and Lichtenstein L.M. Drugs used in the treatment of asthma. In: Hardman J.G., Limbird L.L., and Goodman Gilman A. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. Tenth edition (2001), Mc Graw-Hill, New York 733-754
10. Barnes P.J. New drugs for asthma. Nat Rev Drug Discov 3 (2004) 831-844
11. Spooner C.H., Spooner G.R., and Rowe B.H. Mast-cell stabilising agents to prevent excercise-induced bronchoconstriction. Cochrane Database Syst Rev 4 (2003) CD002307
12. Ratner P.H., Ehrlich P.M., Fineman S.M., Meltzer E.O., and Sekoner D.P. Use of intranasal cromolyn sodium for allergic rhinitis. Mayo Clin Proc 77 (2002) 350-354
13. Moore C., Ehlayel M.S., Junprasert J., and Sorensen R.U. Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis. Ann Allergy Asthma Immunol 81 5 Pt1 (1998) 452-458
14. Owen C.G., Shah A., Henshaw K., Smeeth L., and Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and beta-analysis of efficacy and effectiveness. Br J Gen Pract 54 (2004) 451-456
15. Hubner K., and Darlath W. Therapy of leg ulcers with disodium cromoglycate (DNCG)-case reports. Z Hautkr 57 (1982) 1037-1043
16. Cook E.B., Sathl J.L., Barney N.P., and Graziano F.M. Mechanisms of antihistamines and mast cell stabilizers in ocular allergic inflammation. Curr Drug Targets Inflamm Allergy 1 (2002) 167-180
17. Kucukozkan T., Ersoy B., Uygur D., and Gundogdu C. Prevention of adhesions by soidum chromoglycate, dexametasone, saline and aprotinin after pelvic surgery. ANZ J Surg 74 (2004) 1111-1115
18. Zuo Y., Perkins N.M., Tracey D.J., and Geczy C.L. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 105 (2003) 467-479
19. Pearce F.L., Al-Laith M., Bosman L., Borstoff J., Cunniffe T.M., Flint K.C., et al. Effects of sodium chromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations. Drugs 37 (1989) 37-43
20. Inoue Y., Endo S., Kondo K., Ito H., Omori H., and Saito K. Trial of electrolyzed strong acid aqueous solution lavage in the treatment of peritonitis and intraperitoneal abscess. Artif Organs 21 (1997) 28-31
21. Nakae H., and Inaba H. Effectiveness of electrolyzed oxidized water irrigation in a burn-wound infection model. J Trauma 49 (2000) 511-514
22. Ohno H., Higashidate M., and Yokosuka T. Mediastinal irrigation with super-oxidized solution after open heart surgery: the safety and pitfalls of cardiovascular surgical application. Surg Today 30 (2000) 1055-1056
23. Sampson M.N., and Muir A.V. Not all the super-oxidized solutions are the same. J Hosp Infect 52 (2002) 228-229
24. Landa-Solis C., Gonzalez-Espinosa D., Guzman-Soriano B., Snyder M., Reyes-Teran G., Torres K., et al. Microcyn™: a novel super-oxidized solution with neutral pH and disinfectant activity. J Hosp Infect 61 (2005) 291-299
25. Tanaka H., Hirakata Y., Kaku M., Yoshida R., Takemura H., Mizukane R., et al. Antimicrobial activity of super-oxidized solution. J Hosp Infect 34 (1996) 43-49
26. Dalla Paola L., Brocco E., Senesi A., Merico M., De Vido D., Assaloni R., et al. Super-oxidized solution (SOS) therapy for infected diabetic foot ulcers. Wounds 18 (2006) 262-270
27. Bogiovanni C., Bomengen RW., and Hughes M.D. Superoxidized solution: spectrum of clinical applications. Diabetic Foot Global Conference Hollywood, Ca. USA 23rd-25th March (2006)
28. Miranda-Altamirano A. Reducing bacterial infectious complications from burn wounds. A look at the use of Oculus Microcyn60 to treat wounds in Mexico. Wounds (Jan. 2006) 17-19 (Suppl)
29. Goretti C, Mazzurco S, Ambrosini Nobili L, Macchiarini S, Tedeschi A, Palumbo F, et al. Use of a novel antiseptic super-oxidised solution (SOS) in the management of wide post-surgical lesion in the infected diabetic foot. Int J Low Extrem Wounds 2007;6:22-7.
30. Gutiérrez AA. The science behind stable, super-oxidized solution. Exploring the various applications of super-oxidized solutions. Wounds. Jan 2006 (Suppl), 7-10.
31. Huff T.F., Lantz C.S., Ryan J.J., and Leftwich J.A. Mast cell-committed progenitors. In: Kitamura Y., Yamamoto S., Galli S.J., and Greaves M.W. (Eds). Biological and molecular aspects of mast cell differentiation and function (1995), Raven Press, New York 105-117
32. Saitoh S., Arudchandran R., Manetz T.S., Sommers C.L., Zhang W., Love P.E., et al. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12 (2000) 525-535
33. Hidalgo E., and Domínguez C. Growth-altering effects of sodium hypochlorite in cultured human dermal fibroblasts. Life Sci (2000) 1331-1334
34. Gonzalez-Espinosa C., Odom S., Olivera A., Hobson P.J., Cid-Martinez M.E., Oliveira-dos-Santos A., et al. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med 197 (2003) 1453-1465
35. Hallet M.B., Hodges R., Cadman M., Blanchfeld H., Dewitt S., Pettit E.J., Blanchfeld H., et al. Techniques for measuring and manipulating free Ca2+ in the cytosol and organelles of neutrophils. J Immunol Methods 232 (1999) 77-88
36. Barker S.A., Lujan D., and Wilson B.S. Multiple roles for PI3-Kinase in the regulation of PLC gamma activity and Ca2+ mobilization in antigen-stimulated mast cells. J Leukoc Biol 65 3 (1999) 321-329
37. Common and distinct signaling pathways mediate the induction of TNF-α and IL-5 in IgE plus antigen-stimulated mast cells. J Immunol 160 1 (1998) 273-283
38. Rivera J., Furumoto Y., Gonzalez-Espinosa C., Kovarova M., Odom S., and Parravicini V. Functional coupling of FcεRI employs two proximal Src family kinases. A new paradigm in mast cell activation. In: Bienenstock J., Ring J., and Togias A.G. (Eds). Allergy frontiers and future. Proceedings of the 24th Symposium of the Collegium Internationale Allergologicum (2004), Hogrefe and Huber, Cambridge, MA 152-156
39. Gordon J.R. FcεRI-induced cytokine production and gene expression. In: Hamawy M.M. (Ed). IgE receptor (FcεRI) function in mast cell and basophils (1997), RG Landes Company, Austin, Tx 209-242
40. Carvalho H., Evelson P., Sigaud S., and Gonzalez-Flecha B. Mitogen-activated protein kinases modulate H(2)O(2)-induced apoptosis in primary rat alveolar epithelial cells. J Cell Biochem 92 (2004) 502-513
41. Blank U., and Rivera J. The ins and outs of mast cell exocytosis. Trends Immunol 25 (2004) 266-273
42. Mancel E., Drouet M., and Sabbah A. Membrane stabilizers (chromones and ketotifen). Allerg Immunol (Paris) 31 (1999) 103-105
43. Suzuki T., Masuda M., Friesen M.D., Fenet B., and Ohshima H. Novel products generated from 2'-deoxyguanosine by hypochlorous acid or a myeloperoxidase -H2O2-Cl-system: identification of diimino-imidazole and amino-imidazolone nucleosides. Nucleic Acids Res 30 (2002) 2555-2564
44. Len S.V., Hung Y.C., Erickson M., and Kim C. Ultraviolet spectrophotometric characterization and bactericidal properties of electrolyzed oxidizing water as influenced by amperage and pH. J Food Prot 63 (2000) 1534-1537